Long-term subcutaneous treprostinil therapy evokes both survival benefits and continuous dose-dependent efficacy improvements in patients with pulmonary arterial hypertension

被引：0
|
作者：
Vachiery, JL [1 ]
Gautier, MT [1 ]
Huez, S [1 ]
Retailleau, K [1 ]
Naeije, R [1 ]
机构：
[1] Erasme Univ Hosp, Dept Cardiol, B-1070 Brussels, Belgium
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1849
引用
收藏
页码：400 / 400
页数：1
相关论文
共 50 条
  • [21] Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arterial Hypertension (TRIUMPH) study open-label extension
    Benza, Raymond L.
    Seeger, Werner
    McLaughlin, Vallerie V.
    Channick, Richard N.
    Voswinckel, Robert
    Tapson, Victor F.
    Robbins, Ivan M.
    Olschewski, Horst
    Rubin, Lewis J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (12): : 1327 - 1333
  • [22] Long-Term Survival of Patients with Pulmonary Arterial Hypertension at a Single Center in Taiwan
    Wang, Le-Yung
    Lee, Kuang-Tso
    Lin, Chia-Pin
    Hsu, Lung-An
    Wang, Chun-Li
    Hsu, Tsu-Shiu
    Ho, Wan-Jing
    ACTA CARDIOLOGICA SINICA, 2017, 33 (05) : 498 - 509
  • [23] Drug therapy increases long-term survival in pulmonary hypertension patients
    Senior, K
    LANCET, 2002, 360 (9334): : 696 - 696
  • [24] Choice of Initial Oral Therapy for Pulmonary Arterial Hypertension: Age and Long-Term Survival
    Heresi, Gustavo A.
    Love, Thomas E.
    Tonelli, Adriano R.
    Highland, Kristin B.
    Dweik, Raed A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (08) : 1090 - 1093
  • [25] Long-term tolerability, side effects, dosing regimens and survival with first-line subcutaneous treprostinil for severe pulmonary hypertension
    Sadushi-Kolici, R.
    Skoro-Sajer, N.
    Bonderman, D.
    Martischnig, A.
    Schemper, M.
    Klepetko, W.
    Glatz, J.
    Jakowitsch, J.
    Lang, I. M.
    EUROPEAN HEART JOURNAL, 2010, 31 : 764 - 764
  • [26] Long-term survival comparison in patients with primary and secondary pulmonary arterial hypertension treated with chronic epoprostenol therapy
    Bedi, MS
    Spates-Panyon, J
    Mathier, MM
    Kapoor, A
    MacGowan, GA
    McNamara, DM
    Murali, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 258A - 258A
  • [27] Sex differences in hemodynamic responses and long-term survival to optimal medical therapy in patients with pulmonary arterial hypertension
    Katsuya Kozu
    Koichiro Sugimura
    Tatsuo Aoki
    Shunsuke Tatebe
    Saori Yamamoto
    Nobuhiro Yaoita
    Toru Shimizu
    Kotaro Nochioka
    Haruka Sato
    Ryo Konno
    Kimio Satoh
    Satoshi Miyata
    Hiroaki Shimokawa
    Heart and Vessels, 2018, 33 : 939 - 947
  • [28] Sex differences in hemodynamic responses and long-term survival to optimal medical therapy in patients with pulmonary arterial hypertension
    Kozu, Katsuya
    Sugimura, Koichiro
    Aoki, Tatsuo
    Tatebe, Shunsuke
    Yamamoto, Saori
    Yaoita, Nobuhiro
    Shimizu, Toru
    Nochioka, Kotaro
    Sato, Haruka
    Konno, Ryo
    Satoh, Kimio
    Miyata, Satoshi
    Shimokawa, Hiroaki
    HEART AND VESSELS, 2018, 33 (08) : 939 - 947
  • [29] Real-world, long-term survival of incident patients with pulmonary arterial hypertension
    Marques-Alves, P.
    Baptista, R.
    Marinho da Silva, A.
    Pego, M.
    Castro, G.
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2017, 23 (03) : 124 - 131
  • [30] Impact of Initial Triple Combination Therapy on Long-Term Survival in Pulmonary Arterial Hypertension (PAH)
    Boucly, A.
    Savale, L.
    Weatherald, J. C.
    Montani, D.
    Cottin, V.
    Dauphin, C.
    Picard, F.
    Fard, D.
    Mignard, X.
    Jutant, E.
    Jevnikar, M.
    Jais, X.
    Simonneau, G.
    Humbert, M.
    Sitbon, O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345